Is it possible to get a Wegovy prescription online without having to visit a doctor in person?

Wegovy is a prescription weight loss medication approved by the FDA for chronic weight management in adults with a BMI of 30 or higher or a BMI of 27 or higher with one or more weight-related condition.

Semaglutide, the active ingredient in Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps reduce food intake and increase feelings of fullness.

The most common side effects of Wegovy include nausea, vomiting, constipation, and abdominal pain, according to the FDA.

Wegovy is typically prescribed for patients who are obese with a BMI of 35 or higher, or who are at least 18 years old with a BMI of 27 or higher who have one or more weight-related condition.

Patients should take Wegovy once a week by self-injecting a 2.4 mg dose under the skin in the abdomen.

Doctors may also recommend lifestyle changes such as a healthy diet and regular exercise to support weight loss and weight maintenance.

Online healthcare platforms, such as ReflexMD, offer Wegovy prescriptions online with no consultation fee and fast shipping.

The list price for Wegovy before insurance or discounts is $1,349.02 for a box of four pens, which is a 1-month supply.

Patients can apply for savings via NovoCare, which may reduce the cost of Wegovy to $25 per 28-day prescription for up to 6 fills.

Eligible patients can receive savings of up to $200 at NovoCare.com for their Wegovy prescription.

Online pharmacies, such as Amazon Pharmacy, allow patients to transfer their prescriptions and receive free shipping for Prime members.

Wegovy is an injectable prescription medicine used with a reduced-calorie diet and increased physical activity to reduce the risk of major cardiovascular events.

GLP-1 receptor agonists, such as semaglutide, work by mimicking the action of the hormone glucagon-like peptide-1, which helps regulate appetite and metabolism.

Studies have shown that GLP-1 receptor agonists can reduce body weight and improve cardiovascular outcomes in patients with obesity and related conditions.

Wegovy has a box warning, the FDA's strongest warning, due to increased risk of thyroid C-cell tumors.

Patients should not take Wegovy if they have a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2.

Wegovy may increase the risk of acute pancreatitis, and patients should be monitored for signs and symptoms of pancreatitis.

The most common adverse reactions to Wegovy include nausea, vomiting, diarrhea, abdominal pain, and injection site reactions.

Patients should not take Wegovy with other GLP-1 receptor agonists or with insulin, as it may increase the risk of hypoglycemia.

Online healthcare platforms, such as Sesame Care, offer step-by-step guides to help patients navigate the process of getting a Wegovy prescription online.